The shRNA-mediated knockdown cell lysate kit for EXOSC3 in HepG2 cells has been validated by Western blot analysis. The kit includes EXOSC3 knockdown cell lysate, matched wild-type cell lysate, and a knockdown-validated anti-EXOSC3 monoclonal antibody for confirmation of target specificity in Western blot applications.
Konzentration:
Cell Lysate: 2 mg/mL, Antibody: lot specific
Formulierung:
Liquid
Proben:
HepG2
Target-Kategorie:
EXOSC3
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
